St. Luke's Hospital is a clinical research site located in Easton, Pennsylvania, United States 18045.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
St. Luke's Hospital has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Renal Cell Carcinoma, Refractory Solid Tumors, Melanoma.
Sponsors: Xynomic Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Bristol-Myers Squibb.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St. Luke's Hospital has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Luke's Hospital has 3 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma, Refractory Solid Tumors, Melanoma.
St. Luke's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.